Barclays
NHC icon

Barclays’s National Healthcare NHC Stock Holding History

Barclays’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Sell
2,512
-17,293
-87% -$2.65M ﹤0.01% 3310
2025
Q4 		$2.72M Buy
19,805
+1,820
+10% +$235K ﹤0.01% 2707
2025
Q3 		$2.19M Sell
17,985
-6,071
-25% -$655K ﹤0.01% 2824
2025
Q2 		$2.57M Buy
24,056
+8,038
+50% +$803K ﹤0.01% 2658
2025
Q1 		$1.49M Sell
16,018
-6,229
-28% -$604K ﹤0.01% 2863
2024
Q4 		$2.39M Buy
22,247
+1,184
+6% +$144K ﹤0.01% 2753
2024
Q3 		$2.65M Buy
21,063
+16,336
+346% +$2.05M ﹤0.01% 2619
2024
Q2 		$512K Sell
4,727
-6,859
-59% -$669K ﹤0.01% 3030
2024
Q1 		$1.09M Sell
11,586
-9,379
-45% -$888K ﹤0.01% 3046
2023
Q4 		$1.94M Buy
20,965
+12,346
+143% +$946K ﹤0.01% 2947
2023
Q3 		$551K Sell
8,619
-807
-9% -$51.7K ﹤0.01% 2741
2023
Q2 		$583K Sell
9,426
-3,375
-26% -$200K ﹤0.01% 2656
2023
Q1 		$743K Buy
12,801
+9,423
+279% +$542K ﹤0.01% 2966
2022
Q4 		$201K Buy
3,378
+2,845
+534% +$172K ﹤0.01% 3839
2022
Q3 		$34K Sell
533
-99
-16% -$6.88K ﹤0.01% 3895
2022
Q2 		$44K Sell
632
-1,469
-70% -$103K ﹤0.01% 4079
2022
Q1 		$147K Sell
2,101
-13,144
-86% -$884K ﹤0.01% 3604
2021
Q4 		$1.04M Buy
15,245
+4,678
+44% +$324K ﹤0.01% 2814
2021
Q3 		$739K Buy
10,567
+4,834
+84% +$352K ﹤0.01% 2970
2021
Q2 		$400K Sell
5,733
-8,445
-60% -$614K ﹤0.01% 3198
2021
Q1 		$1.1M Buy
14,178
+10,128
+250% +$717K ﹤0.01% 2715
2020
Q4 		$269K Sell
4,050
-1,688
-29% -$111K ﹤0.01% 3596
2020
Q3 		$358K Sell
5,738
-1,488
-21% -$93.1K ﹤0.01% 3470
2020
Q2 		$458K Buy
7,226
+3,145
+77% +$211K ﹤0.01% 3405
2020
Q1 		$293K Sell
4,081
-8,373
-67% -$662K ﹤0.01% 4013
2019
Q4 		$1.08M Buy
12,454
+5,871
+89% +$491K ﹤0.01% 3607
2019
Q3 		$538K Sell
6,583
-2,031
-24% -$168K ﹤0.01% 4189
2019
Q2 		$698K Buy
8,614
+128
+2% +$9.88K ﹤0.01% 4039
2019
Q1 		$644K Buy
8,486
+4,052
+91% +$321K ﹤0.01% 3871
2018
Q4 		$349K Sell
4,434
-5,390
-55% -$422K ﹤0.01% 4150
2018
Q3 		$741K Buy
9,824
+8,938
+1,009% +$658K ﹤0.01% 3921
2018
Q2 		$62K Sell
886
-2,641
-75% -$173K ﹤0.01% 5534
2018
Q1 		$211K Buy
3,527
+329
+10% +$20.2K ﹤0.01% 4790
2017
Q4 		$194K Buy
3,198
+2,139
+202% +$136K ﹤0.01% 4720
2017
Q3 		$66K Sell
1,059
-571
-35% -$36.8K ﹤0.01% 5193
2017
Q2 		$114K Buy
1,630
+1,432
+723% +$102K ﹤0.01% 4814
2017
Q1 		$15K Sell
198
-14,534
-99% -$1.08M ﹤0.01% 5926
2016
Q4 		$1.12M Sell
14,732
-21,611
-59% -$1.5M ﹤0.01% 2640
2016
Q3 		$2.4M Buy
36,343
+4,217
+13% +$274K ﹤0.01% 1848
2016
Q2 		$2.08M Buy
32,126
+29,903
+1,345% +$1.9M ﹤0.01% 1974
2016
Q1 		$138K Buy
+2,223
New +$138K ﹤0.01% 4126
2015
Q4 		– Sell
-52
Closed -$3K – 6376
2015
Q3 		$3K Sell
52
-142
-73% -$8.89K ﹤0.01% 6226
2015
Q2 		$12K Sell
194
-113
-37% -$7.17K ﹤0.01% 6006
2015
Q1 		$19K Sell
307
-530
-63% -$33.7K ﹤0.01% 5860
2014
Q4 		$52K Buy
837
+494
+144% +$29.7K ﹤0.01% 5683
2014
Q3 		$19K Buy
343
+157
+84% +$8.87K ﹤0.01% 6513
2014
Q2 		$10K Sell
186
-234
-56% -$12.7K ﹤0.01% 6831
2014
Q1 		$23K Sell
420
-160
-28% -$8.38K ﹤0.01% 6529
2013
Q4 		$30K Buy
580
+473
+442% +$24.2K ﹤0.01% 6490
2013
Q3 		$5K Sell
107
-37
-26% -$1.77K ﹤0.01% 6985
2013
Q2 		$7K Buy
+144
New +$6.72K ﹤0.01% 7260

Other funds holding NHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's NHC Position: Q1 2026 in Review

Barclays reduced its National Healthcare (NHC) stake by 87% in Q1 2026, selling an estimated $2.65M and leaving 2,512 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Barclays first reported a position in NHC in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.72M in Q4 2025. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Barclays held 2,512 shares of National Healthcare worth $401K as of Q1 2026.
  • Barclays sold 17,293 National Healthcare shares in Q1 2026, an estimated $2.65M.
  • National Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3310 holding.
  • Barclays first reported a position in National Healthcare in Q2 2013 and has held it in 51 quarters since.
  • Barclays's National Healthcare position peaked at $2.72M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.